Hu, Heng-long
4379  Ergebnisse:
Personensuche X
?
2

Toll-Like Receptor 4 as a Favorable Prognostic Marker in Bl..:

Lu, Jun-Lin ; Xia, Qi-Dong ; Sun, Yi...
Frontiers in Cell and Developmental Biology.  9 (2021)  - p. , 2021
 
?
3

Efficacy and toxicity in scheduled intravesical gemcitabine..:

Lu, Jun-Lin ; Xia, Qi-Dong ; Liu, Chen-Qian...
Translational Cancer Research.  10 (2021)  6 - p. 2849-2858 , 2021
 
?
4

Antioxidants may contribute in the fight against ageing: an..:

Hu, Heng-long ; Forsey, R.J ; Blades, Tony J...
Mechanisms of Ageing and Development.  121 (2001)  1-3 - p. 217-230 , 2001
 
?
6

Toll-Like Receptor 4 as a Favorable Prognostic Marker in Bl..:

Lu, Jun-Lin ; Xia, Qi-Dong ; Sun, Yi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204102/.  , 2021
 
?
8

Resveratrol Protects PC12 Cells from High Glucose-Induced N..:

Liu, Mi-Hua ; Yuan, Cong ; He, Jun...
Cellular and Molecular Neurobiology.  35 (2014)  4 - p. 513-522 , 2014
 
?
9

Meta-Analysis of Atrial Fibrillation and Outcomes in Patien..:

Liu, Gang ; Long, Ming ; Hu, Xun..
Heart, Lung and Circulation.  30 (2021)  5 - p. 698-706 , 2021
 
?
10

Meta-Analysis of the Impact of Pre-Procedural Serum Albumin..:

Liu, Gang ; Hu, Xun ; Long, Ming...
International Heart Journal.  61 (2020)  1 - p. 67-76 , 2020
 
?
15

Toll-Like Receptor 4 as a Favorable Prognostic Marker in Bl..:

Jun-Lin Lu ; Qi-Dong Xia ; Yi Sun...
https://www.frontiersin.org/articles/10.3389/fcell.2021.651560/full.  , 2021
 
1-15